Renvilda M 1000 Tablet is primarily employed in the management of type 2 diabetes mellitus in adults. It belongs to a class of medicines categorised as anti-diabetic agents.
Renvilda M 1000 Tablet is indicated for:
• Managing type 2 diabetes in adults
• Improving blood glucose control in conjunction with diet and exercise
• Follow the exact dosage and timing as instructed by your doctor.
• Do not alter or exceed the prescribed dose without consulting your doctor.
• Consult your doctor before ceasing the medication; do not discontinue without guidance.
Renvilda M 1000 Tablet is taken orally.
Renvilda M 1000 Tablet may cause several side effects, including:
• Diarrhoea
• Nausea
• Vomiting
• Abdominal pain
Renvilda M 1000 Tablet comprises two active components:
• Vildagliptin (50 mg): As a dipeptidyl peptidase-4 (DPP-4) inhibitor, vildagliptin inhibits the enzyme DPP-4, which degrades incretin hormones GLP-1 and GIP. Consequently, this action elevates incretin levels, augmenting insulin secretion from pancreatic beta cells in the presence of elevated blood glucose.
• Metformin (1000 mg): This agent reduces hepatic glucose production and decreases intestinal glucose absorption. It enhances insulin sensitivity by facilitating peripheral glucose uptake and utilisation. Combined, metformin and vildagliptin enhance the body's response to endogenous insulin, reduce hepatic glucose synthesis, and promote insulin-dependent glucose uptake in tissues.
Exercise caution and consult your doctor before taking this medicine if you are pregnant.
It is not recommended to use Renvilda M 1000 Tablet while breastfeeding. Consult your doctor to evaluate potential risks and benefits.
Avoid alcohol consumption as it may increase the risk of lactic acidosis, a rare but serious adverse reaction related to metformin.
Discuss any liver-related concerns with your doctor prior to commencing treatment with Renvilda M 1000 Tablet.
Exercise caution if you have a history of renal issues. Consult your doctor before starting this medicine.
Use caution when driving or operating machinery, as dizziness or tremors may occur.
Avoid taking Renvilda M 1000 Tablet if you have allergies to metformin, vildagliptin, or other ingredients in the tablet.
This medicine is not recommended for individuals under the age of 18.
Older adults should use Renvilda M 1000 Tablet under medical supervision due to increased susceptibility to side effects. Caution is advised for patients over 70 years.
Drug-Drug Interactions
• Cationic Medicines: May increase the risk of metformin accumulation and lactic acidosis when taken with Renvilda M 1000 Tablet.
• Other Anti-diabetics: When combined with Renvilda M 1000 Tablet, other anti-diabetic medications can increase the risk of hypoglycaemia.
Drug-Disease Interactions
• Diabetic Ketoacidosis: This medicine is contraindicated for those suffering from diabetic ketoacidosis due to insufficient insulin production.
Daily Dosage
• Take Renvilda M 1000 Tablet as directed by your doctor. The dosage may change based on individual factors such as the severity of the condition and response to treatment. It is important to follow the prescribed dosage and not exceed it without consulting your doctor.
Missed Dose
• If you miss a dose, take it as soon as you remember. If it is nearly time for your subsequent dose, skip the missed dose and continue with your usual schedule. Do not double the dose without consulting your doctor.
Overdose
• Common symptoms of overdose include nausea, vomiting, and diarrhoea. If an overdose occurs, seek medical attention promptly.
• Store Renvilda M 1000 Tablet at a temperature below 30°C.
• Protect from excessive light and moisture.
• Keep out of reach of children.
• Ensure the medicine is used before the expiry date indicated on the packaging.
• Maintain a balanced diet with low sugar content to manage type 2 diabetes effectively.
• Engage in regular physical activity, such as walking or swimming, to control blood glucose levels.
.avif)
%20(1).png)
.webp)